Diagnostic Excellence in Dementia Care White Paper

Learn more about barriers to timely and accurate dementia diagnosis, and how a systems safety strategy can improve diagnostic excellence. ECRI's white paper: Diagnostic Excellence in Dementia Care ...

Kentucky law prevents practitioners from being criminally charged for medical errors

We were pleased to learn that Kentucky Governor Andy Beshear recently signed a bill (House Bill 159) into law that protects healthcare practitioners from being criminally charged for medical errors...

ISMP Urges Increased Action at the Practice Level to Halt the Growing Danger of Counterfeit Drugs

Problem: Counterfeit drugs, or fake drugs, made to resemble genuine pharmaceutical manufacturers’ medications (Figure 1), have been a longstanding threat to the health and safety of patients. Alarm...

What Hospitals Need to Know: Using Water During Processing of Medical Devices

Every day, hospitals’ central sterile processing teams rely on water as they clean and sterilize a variety of medical devices. In this blog, ECRI outlines general considerations to support safe and...

Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...

Implement Strategies to Prevent Persistent Medication Errors and Hazards: 2024

Reflecting on events that occurred in 2023, we have identified the top three medication errors and hazards that were recurring themes in the ISMP Medication Safety Alert!, which our affiliate ECRI,...

ECRI’s Top 10 Patient Safety Concerns for 2024

ECRI recently published our Top 10 Patient Safety Concerns for 2024 Special Report—the annual guide that calls attention to pressing patient safety concerns facing the healthcare industry. For thi...

IWD 2024: How to Continue Progress in Cervical Cancer Screening

International Women’s Day is an opportune time to celebrate improvements in women’s health outcomes—and reflect on steps we can take to achieve even more progress. For this blog, we’re focusing on ...

Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know

Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States. Uptake for these two glucagon-l...